{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:41:43Z","timestamp":1769798503223,"version":"3.49.0"},"reference-count":61,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The retina, one of the most metabolically active tissues in the human body, is susceptible to a wide range of injuries [...]<\/jats:p>","DOI":"10.3390\/ijms27031376","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:19:38Z","timestamp":1769761178000},"page":"1376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue: Molecular Mechanisms and Treatment of Retinal Diseases"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-9039","authenticated-orcid":false,"given":"Deokho","family":"Lee","sequence":"first","affiliation":[{"name":"The Korean Institute of Nutrition, Hallym University, Chuncheon 24252, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-3342","authenticated-orcid":false,"given":"Livio","family":"Vitiello","sequence":"additional","affiliation":[{"name":"Eye Unit, \u201cLuigi Curto\u201d Hospital, Azienda Sanitaria Locale Salerno, 84035 Polla, SA, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rosa, J.G.S., Disner, G.R., Pinto, F.J., Lima, C., and Lopes-Ferreira, M. (2023). Revisiting Retinal Degeneration Hallmarks: Insights from Molecular Markers and Therapy Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202307.0542.v1"},{"key":"ref_2","first-page":"e99380","article-title":"Retinal Degeneration and Visual Outcomes in Patients With Bardet-Biedl Syndrome: Genotypic Influences From a Caribbean Cohort","volume":"17","author":"Izquierdo","year":"2025","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111374","DOI":"10.4252\/wjsc.v17.i12.111374","article-title":"Novel developments in retinal regeneration: Advances and future outlooks in stem cell therapy","volume":"17","author":"Zeppieri","year":"2025","journal-title":"World J. Stem Cells"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-3-031-76550-6_75","article-title":"Interplay of Retinal and Choroidal Vasculatures in Ocular Health and Disease","volume":"1468","author":"Gonzales","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Khoo, H.E., Ng, H.S., Yap, W.S., Goh, H.J.H., and Yim, H.S. (2019). Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases. Antioxidants, 8.","DOI":"10.3390\/antiox8040085"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e71337","DOI":"10.1002\/fsn3.71337","article-title":"Grape Seed Proanthocyanidins Protect Against Diabetic Retinopathy in Mice","volume":"13","author":"Li","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s00347-025-02328-1","article-title":"Diabetic retinopathy and risk modification through diet and dietary supplements","volume":"122","author":"Chronopoulos","year":"2025","journal-title":"Die Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wu, K.Y., Dhaliwal, J.K., Sasitharan, A., and Kalevar, A. (2024). Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101299"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kim, H.M., and Woo, S.J. (2021). Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010108"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/5584_2025_854","article-title":"Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Glaucoma and Retinal Diseases","volume":"1483","author":"Wu","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4103\/NRR.NRR-D-24-01322","article-title":"Cell-based therapies for traumatic optic neuropathy: Recent advances, challenges, and perspectives","volume":"21","author":"Wang","year":"2026","journal-title":"Neural Regen. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.actbio.2025.01.006","article-title":"3D bioprinting approaches for enhancing stem cell-based neural tissue regeneration","volume":"193","author":"Bektas","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bogdanov, P., Duarri, A., Sabater, D., Canz, M.J., Isla-Magran\u00e9, H., Ramos, H., De\u00e0s-Just, A., Sim\u00f3, R., and Hern\u00e1ndez, C. (2025). Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010048"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bouhenni, R.A., and Edward, D.P. (2025). Role of Ocular Pathology in Understanding Glaucoma. Ocul. Oncol. Pathol., online ahead of print.","DOI":"10.1159\/000549376"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sawada, Y., Morita, M., and Araie, M. (2026). Asymmetric Retinal Nerve Fiber Layer Defects in Early Glaucoma: A Focus on Superior-Inferior Depth Variability. Ophthalmol. Glaucoma, online ahead of print.","DOI":"10.1016\/j.ogla.2026.01.007"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mahalingam, M., Charng, J., Tang, V.T.S., Morgan, B., Chan, G., Turpin, A., and McKendrick, A.M. (2026). Association between vision-related difficulties in low light levels and visual fields in glaucoma. Ophthalmol. Glaucoma, online ahead of print.","DOI":"10.1016\/j.ogla.2026.01.006"},{"key":"ref_17","unstructured":"Williams, A.M., Liang, H.W., Usmani, B., Cassidy, J., and Lin, H.S. (2026). Loss to follow-up and increase in cup-to-disc ratio among glaucoma patients in the IRIS Registry. Can. J. Ophthalmol. (J. Can. D\u2019ophtalmologie), online ahead of print."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.2013.5099","article-title":"Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review","volume":"309","author":"Hollands","year":"2013","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/s41433-025-03924-w","article-title":"Effect of sitagliptin on diabetes-induced hyperpermeability of blood-retinal barrier components","volume":"39","author":"Ramos","year":"2025","journal-title":"Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-024-03283-5","article-title":"Sitagliptin eye drops prevent the impairment of retinal neurovascular unit in the new Trpv2(+\/\u2212) rat model","volume":"21","author":"Ramos","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"D\u00f6rschmann, P., Prinz, M., Schmitkall, G., Roider, J., and Klettner, A. (2025). Specific Assay Protocols for Porcine Single-Eye Retinal Pigment Epithelium Concerning Oxidative Stress and Inflammation. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178434"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bhandari, S.K., Lee, S., and Kim, H.J. (2025). Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010202"},{"key":"ref_23","first-page":"552","article-title":"Age-related macular degeneration: A review of current therapies and new treatments","volume":"83","author":"Kniggendorf","year":"2020","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_24","first-page":"673","article-title":"Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update","volume":"35","author":"Parravano","year":"2021","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo, A., Vitiello, L., Gagliardi, V., Salerno, G., De Pascale, I., Coppola, A., Abbinante, G., Pellegrino, A., and Giannaccare, G. (2024). The Role of Oral Supplementation for the Management of Age-Related Macular Degeneration: A Narrative Review. J. Pers. Med., 14.","DOI":"10.3390\/jpm14060653"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2041731416650838","DOI":"10.1177\/2041731416650838","article-title":"Methods for culturing retinal pigment epithelial cells: A review of current protocols and future recommendations","volume":"7","author":"Fronk","year":"2016","journal-title":"J. Tissue Eng."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jang, H.Y., Cho, C.S., Shin, Y.M., Kwak, J., Sung, Y.H., Kang, B.C., and Kim, J.H. (2023). Isolation and Characterization of the Primary Marmoset (Callithrix jacchus) Retinal Pigment Epithelial Cells. Cells, 12.","DOI":"10.3390\/cells12121644"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-0716-4087-6_13","article-title":"Generation of Induced-Primary Retinal Pigment Epithelium from Human Retinal Organoids","volume":"2848","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"ref_29","first-page":"e66921","article-title":"A Simplified Method for Isolation and Culture of Retinal Pigment Epithelial Cells from Adult Mice","volume":"207","author":"Hubal","year":"2024","journal-title":"J. Vis. Exp. (JoVE)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000223844","article-title":"Culturing of retinal pigment epithelium cells","volume":"43","author":"Valtink","year":"2009","journal-title":"Dev. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nprot.2009.33","article-title":"A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells","volume":"4","author":"Sonoda","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gyenes, A., Istv\u00e1n, L., Papp, A., Resch, M., R\u00e9cs\u00e1n, Z., Ecsedy, M., Szepessy, Z., Szab\u00f3, A., Lesch, B., and Barcsay, G. (2025). Evaluation of the Duration of Good Visual Acuity During Anti-VEGF Therapy for Age-Related Macular Degeneration in Routine Clinical Practice. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262210927"},{"key":"ref_33","first-page":"322","article-title":"Anti-VEGF therapy\u2014A new hope in AMD treatment","volume":"69","author":"Stoica","year":"2025","journal-title":"Rom. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Song, D., Liu, P., Shang, K., and Ma, Y. (2022). Application and mechanism of anti-VEGF drugs in age-related macular degeneration. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.943915"},{"key":"ref_35","first-page":"Cd016298","article-title":"Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): A network meta-analysis","volume":"1","author":"Lucenteforte","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_36","first-page":"Cd005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"8","author":"Solomon","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","first-page":"Cd011346","article-title":"Aflibercept for neovascular age-related macular degeneration","volume":"2","author":"Sarwar","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000438969","article-title":"Neovascular Age-Related Macular Degeneration","volume":"55","author":"Shao","year":"2016","journal-title":"Dev. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/ICU.0b013e32835fefee","article-title":"Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration","volume":"24","author":"Scott","year":"2013","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ophtha.2015.04.028","article-title":"Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration","volume":"122","author":"Veloso","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gale, R., Awad, M.H., Bailey, C., Cackett, P., Chhabra, R., Downey, L., Ghanchi, F., Kotagiri, A., Narendran, N., and Pearce, I. (2026). Aflibercept 8\u2009mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: Guidance from a UK expert panel. Eye, online ahead of print.","DOI":"10.1038\/s41433-025-04180-8"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4103\/tjo.TJO-D-24-00122","article-title":"Effectiveness of aflibercept, ranibizumab, and Ozurdex for treating diabetic macular edema showing a suboptimal response: A comparative observational study","volume":"15","author":"Chassid","year":"2025","journal-title":"Taiwan J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41598-025-31287-5","article-title":"Short-term outcomes and choroidal morphological changes following aflibercept therapy in pachychoroid neovasculopathy","volume":"16","author":"Kim","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Malhotra, K., Colcombe, J., Patil, S., Vail, D., and Parikh, R. (2026). U.S. trends of anti-vascular endothelial growth factor use from 2017\u20132023: An analysis of medicare, medicaid, and commercial insurance. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0335390"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.18240\/ijo.2026.01.10","article-title":"Ranibizumab on optic disc perfusion in central retinal vein occlusion","volume":"19","author":"Li","year":"2026","journal-title":"Int. J. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5637071","DOI":"10.1155\/joph\/5637071","article-title":"Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema","volume":"2025","author":"Chehade","year":"2025","journal-title":"J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Muzi, A., Gregori, G., Mangoni, L., Mogetta, V., Chhablani, J., Fruttini, D., Fiore, T., Rizzo, C., Mariotti, C., and Lupidi, M. (2025). Functional and Structural Impact of Switching to Bevacizumab in neovascular-AMD Patients Treated with Aflibercept or Ranibizumab. Eur. J. Ophthalmol., 11206721251409237.","DOI":"10.1177\/11206721251409237"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Gettinger, K., Lee, D., Tomita, Y., Negishi, K., and Kurihara, T. (2025). Diabetic Retinopathy, a Comprehensive Overview on Pathophysiology and Relevant Experimental Models. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26209882"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"150272","DOI":"10.1016\/j.ijbiomac.2026.150272","article-title":"Oxidative stress in diabetic retinopathy: Metabolic triggers, molecular pathways and emerging antioxidant therapies","volume":"344","author":"Che","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6922946","DOI":"10.1155\/jdr\/6922946","article-title":"Targeting Retinal Neuroglial Vascular Unit Damage: Novel Therapeutic Strategies for Early-Stage Diabetic Retinopathy","volume":"2025","author":"Li","year":"2025","journal-title":"J. Diabetes Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ismail, M.F., Khalafalla, I., Sheck, Z.O., Isse, S.A.S., Farah, F.A., Mohamed, I.A., Qarbote, A.I., Warsame, A.A., Salah, N.A., and Mire, A.M. (2025). Diabetic retinopathy in Sub-Saharan Africa: Prevalence and regional variations from a systematic review and meta-analysis. BMC Ophthalmol., online ahead of print.","DOI":"10.21203\/rs.3.rs-7418780\/v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6654976","DOI":"10.1155\/bmri\/6654976","article-title":"The Role of Diet and Oral Supplementation for the Management of Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review","volume":"2025","author":"Lixi","year":"2025","journal-title":"BioMed Res. Int."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, X., and Liu, H. (2026). 4D-DIA proteomics analysis revealed the network pharmacological mechanism of Astragaloside IV for the treatment of diabetic retinopathy. Xenobiotica, 1\u20138.","DOI":"10.1080\/00498254.2025.2612600"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5.47.41","DOI":"10.1002\/0471141755.ph0547s70","article-title":"Streptozotocin-Induced Diabetic Models in Mice and Rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2013.11.024","article-title":"Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced \u03b2-cell damage and diabetes in mice","volume":"442","author":"Fukaya","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gettinger, K., Lee, D., Negishi, K., and Kurihara, T. (2025). Unilateral Common Carotid Artery Occlusion in Adult Mice with Streptozotocin Comorbidity Leads to Early Retinal Inflammation. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094385"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Abu Serhan, H., Naeem, U., Mohamed, M.S.I., Al Hashimi, M., and Pai, A. (2025). Sub-Internal Limiting Membrane Hemorrhage Following Femtosecond Laser In Situ Keratomileusis: A Rare Postoperative Complication. J. Vitreoretin. Dis., 24741264251405061.","DOI":"10.1177\/24741264251405061"},{"key":"ref_58","first-page":"e44420","article-title":"Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report","volume":"15","author":"Zunaina","year":"2023","journal-title":"Cureus"},{"key":"ref_59","first-page":"e25916","article-title":"Pars Plana Vitrectomy for a Sub-Internal Limiting Membrane Hemorrhage and Vitreous Hemorrhage Secondary to Dengue Fever: A Case Report","volume":"14","author":"Malek","year":"2022","journal-title":"Cureus"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1177\/1120672120934958","article-title":"\u201cArcus retinalis\u201d: A novel clinical marker of sub-internal limiting membrane hemorrhage","volume":"31","author":"Kumar","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Eder, K., Langosz, P., Danikiewicz-Zaga\u0142a, M., Leszczy\u0144ski, R., and Wygl\u0119dowska-Promie\u0144ska, D. (2026). Sub-Internal Limiting Membrane Hemorrhage: Molecular Microenvironment and Review of Treatment Modalities. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031336"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:21:14Z","timestamp":1769761274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031376"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031376","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}